Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Periodic Reporting for period 2 - INSPIRE (INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.)

Berichtszeitraum: 2022-01-01 bis 2024-05-31

INSPIRE has created a long-lasting impact on the field of Safety Pharmacology
Mein Booklet 0 0